List of the Top Clinical Trial Management Software for Nonprofit in 2026 - Page 3

oomnia is the first true all-in-one clinical trial solution that unifies clinical research and clinical practice by offering all relevant tools like EDC, RTSM, CTMS, eTMF, ePRO, eCOA, eConsent, and eSource as integrative parts of one single system. No coding is required due to intuitive drag-and-drop features. oomnia is fully interoperable, eliminating integration issues, and offers role-based access with a user-friendly interface customizable by language and notifications. Real-time reporting, seamless randomization, and complete audit logs enhance efficiency and data accuracy.

The LARVOL CLIN platform provides an extensive array of AI-powered data analytics and intelligence tailored for oncology and drug development professionals, integrating more than 100,000 cancer clinical trials alongside detailed outcomes, digitized Kaplan-Meier curves, forest plots, and real-time social media commentary from a community of over 5,000 oncologists. Users gain access to a cohesive interface that facilitates searches based on condition, intervention, or trial ID, enriched by expert-curated insights and visually appealing dashboards that enhance decision-making. Moreover, the platform includes functionalities such as conference tracking, comprehensive databases for biomarkers and diagnostics, and in-depth market intelligence reports collected from upwards of 25,000 sources, including regulatory agencies, clinical trial registries, and various scientific conferences. This tool is specifically designed to assist pharmaceutical and biotech teams in interpreting trial results, identifying trends, understanding mechanisms of action, and pinpointing biomarkers within disease pipelines, utilizing sophisticated search filters, heat maps, and real-time notifications. By adopting this all-encompassing strategy, users are ensured that they remain knowledgeable and prepared to make insightful choices amid the fast-paced advancements in the field. Ultimately, LARVOL CLIN stands out as an indispensable resource for those navigating the complexities of oncology research and drug development.

REDCap Cloud functions as an all-encompassing data science platform that enables organizations to collect, combine, standardize, analyze, and share clinical and research data that adheres to both real-world and regulatory standards, all within a unified, standards-focused framework. This platform supports the entire lifecycle of randomized clinical trials and real-world evidence research by offering a variety of modules designed for complex trial design and implementation, a centralized hub for clinical data that merges eCRF and non-eCRF sources, and AI/ML functionalities that provide real-time operational and data insights, along with smooth integration with eSource and EHR systems. Furthermore, it boosts patient engagement through features such as ePRO/eCOA and wearable technologies, catering to both hybrid and decentralized trial formats. Its analytics capabilities include provisions for synthetic control arms and digital twins, ensuring compliance with global security regulations. Ultimately, REDCap Cloud aims to break down data silos, reduce vendor fragmentation, enable bidirectional data exchanges, and provide sponsors, CROs, and health systems with thorough visibility and oversight of site performance, study data integrity, and regulatory readiness. By optimizing these processes, organizations can significantly enhance the efficiency and effectiveness of their research initiatives, leading to improved outcomes and insights.

Biorce's Aika is an innovative AI-powered clinical intelligence platform that revolutionizes the clinical trial lifecycle by converting labor-intensive processes for protocol creation and feasibility assessments into streamlined, evidence-based automation. Drawing on insights from nearly one million real-world trials, Aika can rapidly generate initial study protocols, detailed regulatory documents, site feasibility assessments, risk management plans, and other essential components of trials much quicker than traditional methods, thus reducing the likelihood of delays and costly revisions. This platform promotes complete transparency in its recommendation processes, empowering teams to confidently convey their decisions to regulatory bodies while ensuring expert supervision remains intact. Furthermore, Aika effectively marries the rapid efficiency of AI with deep clinical expertise, significantly shortening trial preparation durations from weeks to just days, which minimizes amendment risks and overall project vulnerabilities. By integrating seamlessly into current workflows without necessitating extensive retraining, Aika allows clinical trial teams to prioritize strategic decision-making over tedious administrative responsibilities. As a result, the focus shifts towards enhancing trial outcomes and optimizing resource allocation, ultimately driving innovation in clinical research practices.

LabRelations stands out as a cutting-edge and versatile laboratory platform aimed at streamlining and enhancing scientific and testing processes through the integration of vital modules such as LIMS, ELN, CTMS, and EDC into a unified system that supports everything from sample tracking to experiment documentation, as well as study management and compliance reporting. This all-encompassing tool effectively reduces manual labor, minimizes inaccuracies, and eliminates data silos, allowing laboratories to centralize all pertinent information in one accessible location. Users can create workflow automations based on specific rules, connect instruments and external systems, and maintain comprehensive audit trails to ensure compliance with regulations like GxP and 21 CFR. Additionally, LabRelations offers the capability to customize objects, forms, views, and permissions according to the distinct needs of each laboratory, fostering improved collaboration across different functions while providing real-time insights that span research, quality assurance, clinical studies, and stringent regulatory environments. Consequently, this platform not only enhances operational efficiency but also bolsters the reliability of laboratory processes, paving the way for more innovative scientific advancements. By adopting LabRelations, laboratories can prepare themselves to meet future challenges with greater agility and effectiveness.

CIMS Global offers cutting-edge data science platforms and eClinical solutions aimed at revolutionizing the clinical trial landscape by improving the quality, efficiency, and speed of key processes such as data collection, analysis, monitoring, and regulatory submissions. Their suite of innovative tools includes CRE, DDM, DMC-HUB, and eBinder, along with a complete eClinical Suite designed to support data gathering, analytics, and clinical operations throughout every stage of a trial. Specifically, CRE functions as a multi-tenant, validated Statistical Computing Environment tailored for compliant clinical data analysis, utilizing R, RShiny, and the RStudio IDE within a secure audit-ready framework that complies with 21 CFR Part 11 and GxP regulations. DDM emerges as a patented Dynamic Data Monitoring platform that provides visual insights into cumulative treatment effects through a trial radar screen while also predicting the likelihood of trial success or failure. Moreover, the seamless integration of these advanced solutions not only reinforces CIMS Global's leading position in clinical trial technology but also empowers researchers to attain the best possible outcomes in their studies. This commitment to innovation ensures that every aspect of clinical trial management is streamlined and data-driven.

Longboat is a cloud-based platform tailored to enhance the efficiency of clinical trials, featuring an integrated Guided Compliance toolset that provides ongoing assistance to users throughout the entire process. By equipping clinical trial site personnel with vital resources, Longboat allows them to focus more on patient care. Moreover, participants can conveniently access important study information and receive timely reminders for upcoming visits. The system streamlines the management of protocol amendments, ensuring they are implemented smoothly and effectively. Additionally, Longboat centralizes the secure exchange of regulated documents among sponsors, CROs, and sites, thereby significantly improving the startup process and alleviating the burden of traditionally tedious tasks for all involved in research. With a unified support platform, all primary stakeholders—including clinical operations teams, monitors, site staff, and trial participants—can access tailored content that meets their specific needs. This holistic strategy guarantees that site staff are well-equipped with the necessary tools and resources to stay engaged and compliant while maintaining a strong focus on participant welfare. In this manner, Longboat not only enhances operational efficiency but also significantly enriches the overall experience for everyone participating in the clinical trial, fostering a more collaborative and effective research environment. By prioritizing user needs, Longboat paves the way for innovative solutions in clinical research management.

Ethical eAdjudication is a state-of-the-art software solution designed for endpoint adjudication and the requirements of e-clinical applications. Tailored for study leaders, quality assurance teams, and committee members, this cloud-based platform offers an incredibly intuitive interface. It aids in the efficient management of event databases, supports committee evaluations, and organizes discussions aimed at resolving conflicts and reaching consensus within a GxP compliant environment. By leveraging Ethical eAdjudication, users can conduct independent reviews and adjudication processes with ease, ensuring prompt outcomes while upholding stringent quality control measures. This groundbreaking platform not only optimizes workflows but also fosters enhanced collaboration and decision-making among all involved parties. Ultimately, it represents a significant advancement in the realm of clinical research technology.

Clinical Conductor CTMS is an advanced platform designed for the effective management of clinical trials. It caters to a variety of users including hospitals, research facilities, and asset management firms, as well as site networks, health systems, and contract research organizations (CROs). By utilizing this cloud-based solution, clinical trials can be executed with greater efficiency, enabling research organizations to enhance their decision-making processes. Notable features of this system encompass electronic data capture, enrollment management, document control, and recruitment oversight, among others, providing a comprehensive toolkit for trial management. Ultimately, it streamlines operations and fosters improved outcomes in clinical research endeavors.

Since 2005, Medrio's Electronic Data Capture (EDC) platform and its complementary eClinical solutions like ePRO, RTSM, eConsent, and Direct Data Capture (DDC) have gained the trust of leading pharmaceutical, biotech, CRO, animal health, medical device, and diagnostic organizations. Our reputation is built on providing user-friendly solutions that enhance the efficiency and simplicity of clinical trials across all phases, sizes, and complexities. Users of Medrio can create their databases in an average of 2.8 weeks without needing any programming skills and can easily implement mid-study modifications with just a few clicks. With options ranging from add-on features to comprehensive service packages, Medrio delivers adaptable, modular solutions tailored to meet the precise needs of our clients, ensuring they receive only the services they require. Our cutting-edge software, combined with extensive training and support resources, has resulted in a remarkable 98% customer satisfaction rating, demonstrating our commitment to excellence in the clinical trial landscape. We continuously strive to innovate and improve our offerings to keep pace with the evolving needs of our users.

Zelta serves as a cloud-based platform dedicated to the unified management and acquisition of clinical data, aiming to optimize and improve the processes involved in clinical trials. Its flexible modular structure is tailored to meet the specific requirements of different studies, which leads to quicker and more effective results. With features that include electronic data capture, management of clinical operations—such as randomization and tracking of trial supplies—clinical trial oversight, and electronic trial master file capabilities, Zelta provides thorough supervision of studies. Additionally, it fosters engagement among patients and providers through electronic clinical outcome assessments and e-consent options. Suitable for a range of studies across all phases, therapeutic disciplines, and international locations, Zelta is designed to offer a user-friendly experience with secure single sign-on access available from any location. Its adaptable and scalable framework permits easy customization and seamless integration with both proprietary and third-party technologies, ensuring it can meet various research requirements effectively. This makes Zelta an invaluable tool for researchers looking to streamline their clinical trial efforts.

AcceleTrial™ removes the guesswork involved in selecting and activating clinical trial sites. It operates on a Study Start-up Management System (SSMS) that prioritizes objective data over self-reported metrics, granting access to a vast repository of thousands of ranked sites around the world. These sites are assessed based on three crucial criteria: their relevant therapeutic knowledge, experience in conducting clinical trials, and available patient data. By utilizing this data-driven approach, you can effectively identify the best-fit sites globally for your clinical trials. The platform also supports a quick activation of these sites for patient enrollment through an automated "push and pull" system that is available in multiple languages. Moreover, it simplifies the document collection process with pre-filled templates and offers real-time activity tracking capabilities. Users can quickly adopt the system since it is cloud-based, requiring very little IT setup or training to get going. Additionally, AcceleTrial™ seamlessly integrates with CTMS or other clinical trial management software, which significantly boosts overall operational effectiveness. This groundbreaking method not only enhances the precision of site selection but also speeds up the entire process of study initiation, ensuring that trials can commence without unnecessary delays. Ultimately, AcceleTrial™ represents a significant advancement in the efficiency and reliability of clinical trial management.

Our strategy for aiding your team starts with our groundbreaking, multi-dimensional platform. Clinical StudyPal serves as a complete, customizable, and patient-centered technology designed to optimize your research processes, rendering them faster, simpler, and more cost-effective. Functioning as a mobile application, it promotes collaboration and boosts interaction between sites and patients, while its web interface facilitates efficient study management backed by comprehensive analytics. Furthermore, it operates as a notification system, ensuring that both patients and the study team are kept well-informed at all times. What advantages might Clinical StudyPal provide for your organization? A more critical question could be, what constraints does it present? With our advanced technology and dedication to patient-focused solutions, our committed team is enthusiastic about supporting yours in establishing a smooth and successful trial experience tailored to your specific requirements. Ultimately, our aim is to empower your research initiatives in every conceivable manner, enhancing the overall effectiveness of your studies. By integrating Clinical StudyPal into your workflow, you can harness the full potential of modern technology to advance your clinical research.

g.BSanalyze is an interactive platform that facilitates the processing and analysis of multimodal biosignal data, specifically targeted at clinical research and life sciences. With over 20 years in the market, it has established a presence in more than 70 countries around the globe. This software is recognized as the most comprehensive toolkit available for assessing both non-invasive and invasive functions and dysfunctions related to the brain, heart, and muscles. Its outstanding performance has earned it numerous international accolades. The newest version introduces a wide array of features, including topographic plots, Canonical Correlation Analysis (CCA), advanced filtering capabilities, a cortiQ file importer, improvements for Result2D, and specialized tools for analyzing Cortico-Cortical Evoked Potentials, as well as dedicated toolboxes for electrocorticography (ECoG) and transcranial magnetic stimulation (TMS). The software is also equipped with various sample biosignal datasets encompassing P300, SSVEP, motor imagery, CSP BCIs, Tilt-Table, event-related potentials (EPs), multi-unit activity, continuous flow magnetic (CFM), cortico-cortical evoked potentials (CCEP), and ERD/ERS. Additionally, it features a highly interactive and user-friendly graphical interface that supports the analysis and documentation of EEG, ECoG, EOG, EMG, ECG, spike data, and diverse physical datasets within the MATLAB environment. In summary, g.BSanalyze emerges as a robust solution for researchers and practitioners eager to explore the intricate realms of biosignal analysis, making it an invaluable asset in the field. Furthermore, its continuous updates ensure that users have access to the latest advancements in biosignal research.

Complion's platform caters specifically to the needs of clinical researchers. Our innovative solution guarantees top-tier compliance while minimizing effort and maximizing efficiency. This enables you to focus on what truly matters: enhancing and advancing patient outcomes effectively. Our eReg solution is accessible to all parties involved in clinical trials, including Sponsors, Research Sites, and CROs. By utilizing our platform, you can lower costs, prevent redundancy, and boost staff productivity. The ability to easily archive, view, and obtain signatures from any device is a key feature. Furthermore, an integrated audit trail is designed to ensure precision and mitigate risks related to patient safety and study execution. We proudly serve a diverse clientele that includes hospitals, cancer care facilities, medical centers, multi-specialty clinics, and dedicated research sites, highlighting the platform's versatility and reliability. This comprehensive approach not only streamlines processes but also fosters collaboration among all stakeholders involved in clinical research.

Intrinsic's Clinical Trial Management System (Intrinsic’s CTMS®) is designed with a strong emphasis on user experience, seeking to minimize data entry and improve proactive study oversight. As a cloud-based solution with a streamlined interface, it facilitates thorough management of clinical studies at multiple levels and adopts a task-oriented methodology, representing a notable evolution in trial management tools. Remarkably, Intrinsic® is the first CTMS to achieve seamless compatibility with all Microsoft applications, including Outlook, Excel, SharePoint, and Power BI. The launch of Dynamic Worksheets allows users to easily import extensive datasets and updates from CROs through their clinical trial management software, removing the necessity for complicated system integrations while enabling the creation of 'live' exports for immediate analysis and reporting. Furthermore, Intrinsic CTMS® leverages Power BI, a cloud-based reporting tool, which enables users to generate reports from other clinical systems, such as EDC and IRT, without the complications and costs associated with creating extensive data warehouses. This groundbreaking methodology not only streamlines data management processes but also significantly boosts the overall effectiveness of clinical trial operations. The focus on user-centric design and integration capabilities positions Intrinsic CTMS® as a leader in the evolving landscape of clinical trial management solutions.

Our cutting-edge Smart Protocol system is engineered to integrate automation and advanced intelligence into the architecture of clinical trials through the use of artificial intelligence. This revolutionary system is reshaping the outdated manual methods that research teams have depended upon for designing clinical trials. In the current digital era, it has become nearly impossible for individuals to meticulously examine every aspect necessary for making informed decisions. Additionally, a multitude of organizations hold precious data that often remains underutilized, with documents stored in systems that lack adequate access. As a result, life science companies may end up making substantial and costly decisions based on inadequate information. Our mission is to shift organizations like yours from a focus on document-centric practices to a more insightful, data-driven framework. We are transforming the research and planning processes for clinical trials by removing barriers that keep data from reaching its intended users. To achieve this, we collect vast amounts of trial-related documents from both your internal assets and the public realm, allowing you to concentrate on what truly matters—enhancing patient outcomes. By streamlining access to essential data, we empower teams to make quicker and more effective informed decisions, ultimately leading to more successful trial results in the future. This holistic approach not only improves efficiency but also fosters innovation in clinical research.

BSI CTMS stands out with its cutting-edge interface and smart data visualization features. Our software for managing clinical trials goes beyond mere aesthetics, providing essential tools that support pharmaceutical, biotech, and diagnostics sponsors, as well as contract research organizations (CROs) and academic sites (SMOs), in efficiently overseeing their clinical trials. The ongoing development of BSI CTMS is driven by market demands and involves collaboration with industry stakeholders. What sets BSI CTMS apart is its comprehensive offering that combines CTMS, eTMF, and Study Startup capabilities into a single integrated platform. Unlike traditional standalone solutions like Excel, which fall short in functionality, our software provides a cohesive experience for users. This integration not only streamlines workflows but also enhances overall productivity in the clinical trial process.

ClinSoft™, created internally by Innovate Research, does not involve any external acquisitions or integrations. The software adheres to FDA regulations, including 21 CFR Part 11, GCP, and HIPAA standards, ensuring it is both fully auditable and validated. This user-friendly system facilitates rapid start-up and close-out processes, allowing you to save valuable time and guaranteeing that any amendments or updates to study protocols are implemented efficiently. As a contract research organization based in India, Innovate Research specializes in clinical research and regulatory affairs, ensuring compliance with US FDA 21 CFR Part 11. The platform features secure electronic signatures and records, role-based access control, and an audit trail. Moreover, it includes an intuitive interface for editing checks and setting up case report forms (CRFs), along with reusable frameworks for items, panels, visits, and pages, enhancing usability and efficiency for clinical trials. Additionally, the comprehensive design of ClinSoft™ supports streamlined workflows, ultimately improving overall productivity in clinical research operations.

myClin enhances document management and collaboration with its innovative eTMF solution, making it a vital tool for research teams. Users can easily upload and distribute research documents via secure, centralized channels, ensuring that vital study updates and training materials are accessible without delay. The integrated oversight feature, "File it," enables tracking of who has reviewed and understood the study documents, serving as a reliable record of study execution while also monitoring training activities such as views and downloads at both the team and individual levels. Additionally, to ensure readiness for inspections, our compliance score provides insights into the engagement of each site or study team member with crucial study information, helping identify areas needing improvement. This proactive method not only enhances risk management practices but also promotes continuous development. Setting up a myClin channel for your team can be completed in just a few hours, ensuring a smooth experience from the outset. Discover how myClin can transform your study management processes and bring unparalleled efficiency to your team today.

SMART-TRIAL stands out as the premier EDC platform for the MedTech industry, enabling you to effectively manage your clinical data. It offers a comprehensive set of tools for collecting data in Post-Market Clinical Follow-Up and Clinical Investigations. Designed to empower clinical teams, it ensures they have complete command over their clinical data while maintaining a strong focus on design, compliance, and functionality. With SMART-TRIAL, clinical teams can streamline their workflows and enhance the quality of their research initiatives.

EasyTrial.net is a versatile online platform that provides you with the ability to access study data at your convenience, regardless of your location. This innovative system facilitates collaboration by offering tailored access controls, allowing you to selectively share certain information while limiting access to other sensitive data as required. Furthermore, EasyTrial.net is compliant with GDPR standards, guaranteeing the secure storage of your data. As the lead investigator, you retain full authority over your data, while EasyTrial.net serves as the data processor, prepared to finalize data handling agreements whenever necessary. Our specialization in data security is underscored by our strong focus on IT and cybersecurity measures. Throughout the years, a multitude of clinical trials has been successfully managed using EasyTrial.net, which has garnered the trust and endorsement of various data regulation authorities, hospitals, and educational institutions worldwide, highlighting the platform's reliability and security. This vast experience not only demonstrates our capability but also bolsters our dedication to protecting your sensitive information throughout the entirety of the research process, ensuring peace of mind as you navigate your studies.

Replior stands out as an innovative company that focuses on delivering advanced software solutions tailored for clinical trials, featuring a comprehensive platform that integrates EDC, eConsent, ePRO, and Virtual Visits to optimize trial execution. Our all-encompassing system, known as Trial Online, streamlines the collection and management of data from researchers, participants, and wearable technology efficiently. It is meticulously designed to support decentralized clinical trials (DCT), providing the flexibility to accommodate site visits, remote interactions, or a blend of both. Our journey began two decades ago when we were tasked with developing an online CRF service for a prominent pharmaceutical company, which marked our evolution from an IT operations provider into a specialized software developer focused on clinical data collection. Over time, we have broadened our offerings to provide a full range of data collection services, while our IT operations are adeptly overseen by our highly skilled sister company, Complior. As we forge ahead, our unwavering commitment to innovating and improving clinical trial processes remains central to our purpose, driving us to continually enhance user experience and data integrity in the trials we support.

Data MATRIX provides an all-encompassing SaaS platform tailored specifically for clinical trial management. Established in 2009, the Data MATRIX team has focused on the intricate processing and analysis of clinical data, producing documentation that adheres to the regulations set forth by the Russian Ministry of Health, FDA, and EMA. Our innovative software simplifies the clinical trial workflow, enabling users to effectively oversee and monitor their progress through an online interface. Prior to the initiation of any project, we ensure to thoroughly adjust and validate our software, taking into account every detail necessary for peak performance. With a successful history of completing 180 projects for various pharmaceutical companies, biotech enterprises, and contract research organizations, our solutions have contributed to 6 of the top 10 Big Pharma firms achieving a notable 15% decrease in research and development costs. The commitment of our dedicated team extends beyond projects as they are actively engaged with professional networks that link clinical data professionals such as CDISC, ACDM, SCDM, biostatisticians like ISBC, and medical writers affiliated with EMWA and AMWA. By consistently refining and advancing our offerings, we strive to foster innovation within the clinical research sector, ensuring that our solutions remain at the forefront of industry needs. This commitment to progress not only supports our clients but also enhances the overall landscape of clinical trials globally.

DrugDev Spark™ is recognized as the pioneering all-inclusive clinical operations suite on a global scale. Explore our services below to understand why numerous sponsors, including 9 of the top 10 pharmaceutical companies, and 4 of the leading 5 CROs place their confidence in DrugDev technology. This innovative platform integrates state-of-the-art technology with professional services, showcasing its effectiveness across a multitude of clinical trials. Our solutions have been meticulously tested and refined by sponsors, CROs, and sites of varying sizes in more than 60 countries, covering every phase from planning to closeout. Our vast experience has allowed us to embed best practices into every aspect of our system. As a result, it’s evident why prominent organizations, such as 9 of the top 10 pharmaceutical firms and 4 of the top 5 CROs, have faith in DrugDev technology. The collaboration encouraged by our solutions is reshaping the clinical trial landscape, leading to more streamlined and effective processes for both sponsors and CROs. Many of the leading sponsors and CROs worldwide are harnessing DrugDev solutions to transform their clinical trial methodologies through improved collaboration and innovative approaches, ultimately enhancing the overall research experience. This commitment to excellence is what sets DrugDev apart in the industry.